More Potent Antiplatelet Therapy in Acute Coronary Syndrome Patients With Prior Stroke: Proceed With Caution?
Dual antiplatelet therapy (DAPT) is the current standard of care in patients presenting with acute coronary syndrome. Current American College of Cardiology/American Heart Association/Society for Cardiovascular Angiography and Interventions guidelines for coronary artery revascularization give a class 2a recommendation for choosing ticagrelor or prasugrel over clopidogrel for treatment of ST-segment elevation myocardial infarction and non –ST-segment elevation myocardial infarction as well as a class 3 indication for using prasugrel in the setting of prior transient ischemic attack (TIA) or stroke.
Source: Mayo Clinic Proceedings - Category: Internal Medicine Authors: Christopher M. McKinnie, Mark B. Effron Tags: Editorial Source Type: research
More News: Angiography | Cardiology | Cardiovascular | Clopidogrel | Heart | Heart Attack | Internal Medicine | Ischemic Stroke | Plavix | Stroke